Arkolith/Insider Trading/BBIO/Form 4

Cook Jennifer E.

DirectorBridgeBio Pharma, Inc. (BBIO) · full profile →Form 4 · filed Jun 17, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$6.0M
Net Open-Market Flow
-$6.0M
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 15, 2026Option exercise(M)66K$8.45$557K80K
Jun 15, 2026Option exercise(M)17K$16.75$288K97K
Jun 15, 2026Sell(S)89K$66.62$5.9M8K
Jun 15, 2026Sell(S)2K$67.14$101K7K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 15, 2026Option exercise(M)66K—$039K
Jun 15, 2026Option exercise(M)17K—$034K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001470831-26-000550) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML